Evidence map›Paper›PMID 25922302›Full record

Trial reportBurns : journal of the International Society for Burn Injuries2015

The effect of burn on serum concentrations of sclerostin and FGF23.

Gordon L Klein, David N Herndon, Phuong T Le, Clark R Andersen, Debra Benjamin, Clifford J Rosen

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Burns : journal of the International Society for Burn Injuries, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Bisphosphonate treatment for secondary osteoporosis in children, youth, and young adults: a systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Bone metabolism in pediatric burned patients: A review.Burns : journal of the International Society for Burn Injuries · 2018
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gordon L KleinDepartment of Orthopaedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston, TX 77555, United States; Shriners Hospital for Children-Galveston, Galveston, TX 77550, United States. Electronic address: gordonklein@ymail.com.
David N HerndonShriners Hospital for Children-Galveston, Galveston, TX 77550, United States; Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, United States.
Phuong T LeMaine Medical Research Institute, Scarborough, ME, United States.
Clark R AndersenShriners Hospital for Children-Galveston, Galveston, TX 77550, United States; Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, United States.
Debra BenjaminShriners Hospital for Children-Galveston, Galveston, TX 77550, United States.
Clifford J RosenMaine Medical Research Institute, Scarborough, ME, United States.
Shriners Hospitals for Children - Galveston · US

Funding

Project 9: The role of androgen/corticosteroid in fat, muscle and glucose metabolism of burn victimsP50GM060338 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SZABO, CSABA · 2000 to 2017
$24.2M
NIGMS NIH HHS P50 GM060338NIGMS NIH HHS P50 GM60338
6 · The paper itself

Abstract

Severe burn results in acute bone resorption followed by an adynamic state, most likely due to changes brought about by the inflammatory and glucocorticoid responses to the injury. There is a consequent increase in annual extrapolated fracture incidence in children. While osteoblasts have been reported to disappear from the bone surface and stem cell differentiation into osteoblasts is impaired, the effect of burns on osteocyte function is unknown. We measured serum concentrations of two osteocyte proteins, sclerostin and fibroblast growth factor (FGF)-23 between 6 and 60 days post-burn in pediatric patients, ages 5-18 years who had participated in a randomized controlled double-blind study of acute administration of pamidronate to prevent the resorptive bone loss. While FGF-23 was undetectable in all samples, the plot of sclerostin concentration versus time post-burn yielded a statistically significant difference between slopes, -2.5 in the placebo control group and +3.5 in the group receiving pamidronate, p=0.016 by ANCOVA. The FGF23 data suggest that osteocytes may be apoptotic, although the sclerostin data may indicate partial preservation of osteocyte function in subjects receiving pamidronate or an ectopic source of sclerostin.

Indexed as

Adaptor Proteins, Signal TransducingAdolescentAnalysis of VarianceAnti-Inflammatory AgentsBone Morphogenetic ProteinsBurnsChildChild, PreschoolDiphosphonatesDouble-Blind MethodFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsGenetic MarkersHumansMaleAdaptor Proteins, Signal TransducingAnti-Inflammatory AgentsBone Morphogenetic ProteinsDiphosphonatesFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsGenetic MarkersPamidronateSOST protein, humanBurnsFGF23OsteocytesSclerostin

Identifiers

PMID25922302
PMCPMC4618193
OpenAlexW2021922277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.